US Stock MarketDetailed Quotes

CTXR Citius Pharmaceuticals

Watchlist
  • 4.3700
  • +0.4600+11.76%
Close Jan 7 16:00 ET
  • 4.4000
  • +0.0300+0.69%
Post 17:11 ET
33.77MMarket Cap-0.73P/E (TTM)

About Citius Pharmaceuticals Company

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.

Company Profile

SymbolCTXR
Company NameCitius Pharmaceuticals
Listing DateAug 3, 2017
Issue Price4.13
Founded2007
CEOMr. Leonard L. Mazur
MarketNASDAQ
Employees23
Fiscal Year Ends09-30
Address11 Commerce Drive,1st floor
CityCranford
ProvinceNew Jersey
CountryUnited States of America
Zip Code07016
Phone1-908-967-6677
Websitehttp://www.citiuspharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Leonard L. Mazur
  • Executive Chairman of the Board, Chief Executive Officer and Secretary; Secretary of NoveCite, Inc. and President and Chief Executive Officer of Citius Oncology, Inc.
  • 1.98M
  • Dr. Myron Czuczman, M.D.
  • Chief Medical Officer and Executive Vice President
  • 1.17M
  • Jaime Bartushak
  • Chief Financial Officer, Principal Accounting Officer and Chief Business Officer
  • --
  • Myron Z. Holubiak
  • Executive Vice Chairman of the Board
  • 1.59M
  • Robert J. Smith
  • Independent Director
  • --
  • Suren G. Dutia
  • Lead Independent Director
  • 196.97K
  • Carol Webb
  • Independent Director
  • 190.97K
  • Dr. Eugene Holuka
  • Independent Director
  • 190.97K
  • Dennis M. McGrath, C.P.A.
  • Independent Director
  • 150.13K
Heat List
US
Overall
Symbol
Price
% Chg

No Data